View Single Post
Old 11-28-2007, 01:33 AM   #11
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Joanne I think what you have posted may be oversimplified

there are supposed to be some HERA results at SABCS in December vis a vis
1 yr vs 2 yrs.

Whether they will have divided those out by ER+ vs ER- I don't know (I have heard there were very few "events"--a good thing--which is why they didn't think they could report this until later in 2008. That story changed when they announced they would give an interim report at SABCS.

Don't know if Genentech is really as interested as they were prior to getting Herceptin approved for adjuvant use. I think they are busy looking for other diseases/indications for herceptin use to broaden its market rather than looking back to find out whether survival was prolonged but metastasis occured, merely later (if so, it would not help their marketing). Sorry to sound jaded, but that seems to be the way things go.

Will certainly post if I find any other articles/news items/conference talks on the topic!
Lani is offline   Reply With Quote